Prelude Capital Management’s Sensus Healthcare SRTS Stock Holding History

Prelude Capital Management’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,986	Closed	-$56.7K	–	1331
2025 Q1	$56.7K	Sell	11,986 -600	-5%	-$3.49K	﹤0.01%	1088
2024 Q4	$87.1K	Buy	12,586 +1,808	+17%	+$13.2K	0.01%	1103
2024 Q3	$62.5K	Buy	+10,778	New	+$65.5K	﹤0.01%	1198
2023 Q1	–	Sell	-12,460	Closed	-$92.5K	–	1453
2022 Q4	$92.5K	Sell	12,460 -21,265	-63%	-$192K	﹤0.01%	1084
2022 Q3	$423K	Buy	+33,725	New	+$403K	0.02%	714

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Prelude Capital Management's SRTS Position: Q2 2025 in Review

Prelude Capital Management sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 11,986 shares — an estimated $56.7K sold.

Prelude Capital Management first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $423K in Q3 2022. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

Prelude Capital Management reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 11,986 Sensus Healthcare shares in Q2 2025, an estimated $56.7K.
Prelude Capital Management first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
Prelude Capital Management's Sensus Healthcare position peaked at $423K in Q3 2022.
46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.